Disruptive innovation in acute stroke systems of care

Volume: 17, Issue: 7, Pages: 576 - 578
Published: Jul 1, 2018
Abstract
Alteplase is the only drug approved by the US Food and Drug Administration (FDA) and the European Medical Agency to be used before endovascular thrombectomy for ischaemic stroke. Now, Campbell and colleagues 1 Campbell BCV Mitchell PJ Churilov L et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med. 2018; 378: 1573-1582 Crossref PubMed Scopus (363) Google Scholar showed evidence of a convincing alternative to...
Paper Details
Title
Disruptive innovation in acute stroke systems of care
Published Date
Jul 1, 2018
Volume
17
Issue
7
Pages
576 - 578
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.